Klajnert B, Cortijo-Arellano M, Cladera J, Bryszewska M
Department of General Biophysics, University of Lodz, Poland.
Biochem Biophys Res Commun. 2006 Jun 23;345(1):21-8. doi: 10.1016/j.bbrc.2006.04.041. Epub 2006 Apr 24.
Inhibition of fibril assembly is a potential therapeutic strategy in neurodegenerative disorders such as prion and Alzheimer's diseases. Highly branched, globular polymers-dendrimers-are novel promising inhibitors of fibril formation. In this study, the effect of polyamidoamine (PAMAM) dendrimers (generations 3rd, 4th, and 5th) on amyloid aggregation of the prion peptide PrP 185-208 and the Alzheimer's peptide Abeta 1-28 was examined. Amyloid fibrils were produced in vitro and their formation was monitored using the dye thioflavin T (ThT). Fluorescence studies were complemented with electron microscopy. The results show that the higher the dendrimer generation, the larger the degree of inhibition of the amyloid aggregation process and the more effective are dendrimers in disrupting the already existing fibrils. A hypothesis on dendrimer-peptide interaction mechanism is presented based on the dendrimers' molecular structure.
抑制原纤维组装是治疗诸如朊病毒病和阿尔茨海默病等神经退行性疾病的一种潜在策略。高度分支的球状聚合物——树枝状大分子——是新型且有前景的原纤维形成抑制剂。在本研究中,考察了聚酰胺胺(PAMAM)树枝状大分子(第3代、第4代和第5代)对朊病毒肽PrP 185 - 208和阿尔茨海默病肽Aβ1 - 28淀粉样聚集的影响。体外产生淀粉样原纤维,并使用硫黄素T(ThT)染料监测其形成。荧光研究辅以电子显微镜观察。结果表明,树枝状大分子代数越高,对淀粉样聚集过程的抑制程度越大,并且树枝状大分子在破坏已存在的原纤维方面越有效。基于树枝状大分子的分子结构,提出了关于树枝状大分子 - 肽相互作用机制的假说。